Clearside Biomedical’s Oncology Licensing Partner Doses First Patient in its Phase 2 Study in Patients with Choroidal Melanoma Using SCS Microinjector® for Suprachoroidal Delivery
11 sept. 2020 08h30 HE
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., Sept. 11, 2020 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve...
National Coalition Launches new scEYEnce Campaign
09 sept. 2020 09h00 HE
|
scEYEnce
—Effort points to the vital importance of vision research, how it is improving sight and broader health and well-being—NEW YORK, Sept. 09, 2020 (GLOBE NEWSWIRE) -- A national coalition of 10 leading...
Clearside Biomedical’s Licensing Partner Doses First Patient in its Phase 2 Gene Therapy Trial Using SCS Microinjector® for Suprachoroidal Delivery
09 sept. 2020 08h30 HE
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve...
Nextech Announces New Glaucoma Flowsheet
08 sept. 2020 10h30 HE
|
Nextech Systems, Inc.
TAMPA, Fla., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Nextech Systems, LLC, a leading provider of healthcare technology solutions for specialty providers, today announced a new glaucoma flowsheet and...
Graybug Vision Appoints Robert Breuil as Chief Financial Officer
04 sept. 2020 07h00 HE
|
Graybug Vision, Inc.
REDWOOD CITY, Calif., Sept. 04, 2020 (GLOBE NEWSWIRE) -- Graybug Vision, Inc. (“Graybug”), a clinical stage biopharmaceutical company focused on developing transformative medicines to treat chronic...
Covenant Physician Partners Selects Nextech's Ophthalmology EHR and ASC Solution
03 sept. 2020 10h30 HE
|
Nextech Systems, Inc.
TAMPA, Fla., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Nextech Systems, a leading provider of healthcare technology solutions for specialty providers, today announces their new alliance with Covenant...
ProQR to Participate in Upcoming Investor Conferences
03 sept. 2020 07h00 HE
|
ProQR Therapeutics N.V.
LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a company dedicated to changing lives through the creation of...
Clearside Biomedical Expands Patent Portfolio in the U.S. and Europe
26 août 2020 07h05 HE
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., Aug. 26, 2020 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve...
Ocugen Provides Business Update and Second Quarter 2020 Financial Results
14 août 2020 07h30 HE
|
Ocugen
Two Additional Orphan Drug Designations Granted for OCU400 Modifier Gene Therapy Program Conference Call and Webcast Today at 8:30 a.m. ET MALVERN, Pa., Aug. 14, 2020 (GLOBE NEWSWIRE) -- Ocugen,...
Clearside Biomedical Announces Second Quarter 2020 Financial Results and Provides Corporate Update
10 août 2020 16h05 HE
|
Clearside Biomedical, Inc.
- IND Accepted by FDA for Suprachoroidal CLS-AX (axitinib injectable suspension) -- Expanded Internal Suprachoroidal Pipeline with Two New Preclinical Programs -- Engaged New Contract Manufacturer for...